Details for Patent: 11,896,719
✉ Email this page to a colleague
Which drugs does patent 11,896,719 protect, and when does it expire?
Patent 11,896,719 protects TARPEYO and is included in one NDA.
This patent has five patent family members in three countries.
Drugs Protected by US Patent 11,896,719
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calliditas | TARPEYO | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 215935-001 | Dec 15, 2021 | RX | Yes | Yes | 11,896,719 | ⤷ Subscribe | REDUCTION IN LOSS OF KIDNEY FUNCTION AND REDUCTION OF PROTEINURIA IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN) WHO ARE AT RISK OF DISEASE PROGRESSION, BY RELEASE OF BUDESONIDE FROM THE FORMULATION | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,896,719
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| United Kingdom | 202210430 | ⤷ Subscribe | |||
| United Kingdom | 202217146 | ⤷ Subscribe | |||
| United Kingdom | 202217150 | ⤷ Subscribe | |||
| Taiwan | 202339765 | ⤷ Subscribe | |||
| World Intellectual Property Organization (WIPO) | 2023139285 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
